Resistant cancer cells can be targeted for elimination
Harvard University researchers have identified a unique characteristic of the resistant cancer cells, which could lead to an inhibitor can be repurposed and combined with chemotherapy to improve patient outcomes.
Jessica Lau •
harvard
Aug. 7, 2020 • ~5 min
Aug. 7, 2020 • ~5 min
New method improves transplant safety in mice
The combination of the antibody CD117 and the drug saporin selectively targets blood stem cells, making transplantation safer by limiting collateral damage caused by the current standard of treatment, chemotherapy, and radiation.
Harvard Gazette
• harvard
Feb. 7, 2019 • ~6 min
Feb. 7, 2019 • ~6 min
Serious campus readers share their favorite spooky books for Halloween
In the days before Halloween, we asked Min Jin Lee, Maria Tatar, and other serious campus readers to share with us the stories that have scared them most — and why.
Colleen Walsh
• harvard
Oct. 29, 2018 • ~7 min
Oct. 29, 2018 • ~7 min
/
1